Page last updated: 2024-11-06

prednisolone and Carcinoma, Basal Cell, Pigmented

prednisolone has been researched along with Carcinoma, Basal Cell, Pigmented in 10 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"However, the risk of acquiring skin cancer increases with the length of immunosuppressive therapy."2.67No difference in skin cancer incidence with or without cyclosporine--a 5-year perspective. ( Blohmé, I; Larkö, O, 1992)
" Thus, these mice provide a good model for study of the effects of long-term administration of ARD on at least one type of non-melanoma skin cancer."1.33Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice. ( Epstein, EH; Hebert, J; Hwang, J; Lu, Y; Vogt, A, 2005)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's3 (30.00)18.2507
2000's3 (30.00)29.6817
2010's1 (10.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Yamamoto, S2
Fujita, S2
Mukai, T2
Sawachika, H2
Morita, Y2
Williams, JV1
Revington, PJ1
HALNAN, KE1
Fryer, AA1
Ramsay, HM1
Lovatt, TJ1
Jones, PW1
Hawley, CM1
Nicol, DL1
Strange, RC1
Harden, PN1
Vogt, A1
Hebert, J1
Hwang, J1
Lu, Y1
Epstein, EH1
Akinyemi, E1
Mai, L1
Matin, A1
Maini, A1
Bergfelt, L1
Veness, MJ1
Blohmé, I1
Larkö, O1

Trials

1 trial available for prednisolone and Carcinoma, Basal Cell, Pigmented

ArticleYear
No difference in skin cancer incidence with or without cyclosporine--a 5-year perspective.
    Transplantation proceedings, 1992, Volume: 24, Issue:1

    Topics: Azathioprine; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Foll

1992

Other Studies

9 other studies available for prednisolone and Carcinoma, Basal Cell, Pigmented

ArticleYear
Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.
    Internal medicine (Tokyo, Japan), 2020, 02-15, Volume: 59, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Carcinoma, Basal Cell; Edema; Humans; Hypotrichosis; Lung Neoplas

2020
Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.
    Internal medicine (Tokyo, Japan), 2020, 02-15, Volume: 59, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Carcinoma, Basal Cell; Edema; Humans; Hypotrichosis; Lung Neoplas

2020
Facial basal cell carcinoma in a young patient with Crohn disease.
    The Journal of craniofacial surgery, 2010, Volume: 21, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Carcinoma, Basal Cell; Crohn Disease; Facial Neoplasm

2010
The effect of corticosteroids on the radiation skin reaction. A random trial to assess the value of local application of prednisolone and neomycin ointment after x-ray treatment of basal cell carcinoma.
    The British journal of radiology, 1962, Volume: 35

    Topics: Adrenal Cortex Hormones; Carcinoma, Basal Cell; Humans; Neomycin; Prednisolone; Radiation Protection

1962
Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.
    Carcinogenesis, 2005, Volume: 26, Issue:1

    Topics: Adult; Australia; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Glutathione Transferase;

2005
Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice.
    The Journal of investigative dermatology, 2005, Volume: 124, Issue:1

    Topics: Animals; Carcinoma, Basal Cell; Cyclosporine; Disease Models, Animal; Glucocorticoids; Graft Rejecti

2005
Diffuse large B-cell lymphoma mimicking advanced basal cell carcinoma.
    Journal of the National Medical Association, 2007, Volume: 99, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy

2007
Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Acta dermato-venereologica. Supplementum, 1993, Volume: 180

    Topics: Adenosine Triphosphatases; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Animals; Antigens

1993
Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe?
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:3

    Topics: Adult; Australia; Azathioprine; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cy

1998